Mometasone Furoate Anhydrous

API Product
mometasone-furoate-anhydrous
Product Status:
Commercial
Available Grades:
  • Micronized
  • Non-Micronized
Regulatory Status:
JP DMF
US DMF
CEP
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
83919-23-7
Modes of Application:
  • Topical
  • Inhalation
  • Nasal
Common Indications:
  • Allergic rhinitis
  • Asthma
  • Skin disorders
Last Inspection:
FDA May 2018

Hovione can customize Mometasone Furoate Anhydrous API for inhalation as well as other demanding applications relying on its experience in particle size reduction technologies with tailored made, highly reproducible particle size distributions.

Low amorphous content and high stability with an industry leading impurity profile are also part of our offering.

Hovione Mometasone Furoate Anhydrous API is available since 1999 approved in generic applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API inhalation, e.g. Glycopyrronium Bromide.

 

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Highlight

Contact Us

Please contact us if you have inquiries about our offering

https://go.hovione.com/l/47122/2014-08-06/9grc

Related files

Hovione_Integrated Product List.pdf
pdf (3.08 MB)
Download